Clinical Trial Update: Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP) [Phase 2]

View source ↗

Summary

This Phase 2 study reports efforts to standardize Cupressus arizonica allergen extract and determine its biological activity in histamine-equivalent units (HEP)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Tree Pollen Allergy

Drugs mentioned

• Cupressus arizonica allergen extract (Cupressus arizonica allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Tree Pollen | Phase 2 | Status: COMPLETED